All stock lists
COMPASS Pathways plc (NASDAQ:CMPS)
GB · Delayed Price · Currency is USD
Healthcare · Biotechnology
11.16-0.02 (-0.20%)
Market cap
$1.55B
Health Score
Analyst consensus
Listed since
Sep 18, 2020
Website
Insider Score
––Not scored
CMPS Insider Score
Insiders here have filed 1 Form 4 in the last 90 days, but all of them are share awards, grants or other non-market transactions. Those are compensation, not a decision to buy, so they are not scored.
CMPS analyst forecast
CMPS analyst consensus
Moderate Buy4 ratings
Buy 4 Hold 0 Sell 0
Based on each firm’s most recent rating in the last 3 months — one vote per firm, so a desk that reiterates weekly does not count three times.
CMPS 12-month price target
No published price targets in the last 12 months.
Best analysts covering CMPS
- BTIG100%success rate · 1 call
- Maxim Group100%success rate · 1 call
- RBC Capital67%success rate · 3 calls
- HC Wainwright & Co.50%success rate · 16 calls
Measured by us from each firm’s own rating dates and this stock’s split- and dividend-adjusted closes. How we calculate this.
CMPS analyst ratings
| Firm | Price target | Action | ||||
|---|---|---|---|---|---|---|
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-08-07 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-08-06 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-08-06 |
| — | B. Riley Securities | Buy | — | — | Reiterated | 2026-08-06 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-07-08 |
| — | Stifel | Buy | — | — | Reiterated | 2026-07-08 |
| — | Evercore ISI Group | Outperform | — | — | Upgraded | 2026-07-08 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-07-07 |
| — | Oppenheimer | Outperform | — | — | Reiterated | 2026-07-07 |
| — | BTIG | Buy | — | — | Reiterated | 2026-07-07 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-06-26 |
| — | Maxim Group | Buy | — | — | Reiterated | 2026-05-15 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-05-14 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-05-14 |
| — | BTIG | Buy | — | — | Reiterated | 2026-05-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-04-28 |
| — | BTIG | Buy | — | — | Reiterated | 2026-04-20 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-03-26 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-03-25 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2026-03-02 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-02-18 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2026-02-18 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2026-02-18 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2026-01-23 |
| — | Morgan Stanley | Overweight | — | — | Reiterated | 2025-11-05 |
| — | BTIG | Buy | — | — | Reiterated | 2025-10-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-08-04 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-08-01 |
| — | HC Wainwright& Co. | Buy | — | — | Reiterated | 2025-07-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-07-15 |
| — | Evercore ISI Group | In Line | — | — | Downgraded | 2025-06-23 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-05-12 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2025-03-28 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-03-04 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2025-02-28 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2025-02-13 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2025-01-15 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-11-01 |
| — | Maxim Group | Buy | — | — | Reiterated | 2024-11-01 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-11-01 |
| — | RBC Capital | Outperform | — | — | Reiterated | 2024-09-10 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-08-23 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2024-08-02 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-07-31 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-05-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2024-03-01 |
| — | Canaccord Genuity | Buy | — | — | Reiterated | 2023-08-22 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-08-22 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-08-17 |
| — | EF Hutton | Buy | — | — | Reiterated | 2023-07-13 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-07-06 |
| — | Cantor Fitzgerald | Overweight | — | — | Reiterated | 2023-06-21 |
| — | EF Hutton | Buy | — | — | Reiterated | 2023-06-20 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-06-06 |
| — | EF Hutton | Buy | — | — | Reiterated | 2023-05-30 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-05-15 |
| — | EF Hutton | Buy | — | — | Reiterated | 2023-05-11 |
| — | EF Hutton | Buy | — | — | Reiterated | 2023-04-12 |
| — | HC Wainwright & Co. | Buy | — | — | Reiterated | 2023-03-10 |
| — | Citigroup | Buy | — | — | Reiterated | 2023-03-01 |
CMPS earnings vs. estimates
| Quarter | EPS est. | EPS actual | Revenue est. | Revenue actual |
|---|---|---|---|---|
| 2026-03-24 | -0.41 | -1.00 | $0 | $0 |
| 2026-05-13 | -0.45 | -0.30 | $0 | $0 |
| 2026-08-05 | -0.46 | -0.36 | $0 | $0 |
| 2026-11-03 | -0.36 | 0.00 | $0 | $0 |
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.